If you are ready to improve your golf game, make an appointment with Integrative Therapeutics. Call 636-777-0973 or visit STLGolfDoc.com.

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead ...

Who we Are Luna Integrative Care offers the following: An adult residential program that addresses substance use and mental health disorders, an adolescent intensive outpatient program ...

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched ...

Therapeutics are treatments used to alleviate or prevent a particular disease. Examples of therapeutics include drug therapy, medical devices, nutrition therapy and stem-cell therapies ...

TG Therapeutics missed on the bottom line, but investors were more cheered by the top-line development. TG Therapeutics' nearly $50.5 million in first-quarter product revenue derived entirely from ...

Biopharmaceutical company Nurix Therapeutics (NASDAQ:NRIX) recently reported financials that beat expectations, unleashing a 20% climb in the stock’s share price over the past week. The company ...

Aileron Therapeutics (NASDAQ:ALRN) just reported results for the fourth quarter of 2023. Aileron Therapeutics reported earnings per share of -$1.54. The company did not report any revenue for the ...

Cancer Chemother Rev. 2008;3(4):204-211. Most types of massage (i.e. Swedish, light touch, and foot) result in various levels of symptom relief for patients; however, those receiving Swedish or ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Scope of presentation included trial design, rationale, and blinded baseline data on first 50 patients randomized into the Phase II study evaluating CardiolRx™ in patients with acute myocarditis ...